Background—In patients with chronic heart failure (CHF)， a β-blocker is generally added to a regimen containing an angiotensin-converting-enzyme (ACE) inhibitor. It is unknow.....
Context β-Blockers have been shown to decrease cardiovascular risk in patients with hypertension and type 2 diabetes mellitus (DM); however， some components of the metabolic syndrome are worsened by some .....
关注公众号
安卓客户端
